Bone Marrow Transplant: How Keck Medicine of USC Is Excelling in Survival Outcomes - Takeaways - MDSpire

Bone Marrow Transplant: How Keck Medicine of USC Is Excelling in Survival Outcomes

Preet M. Chaudhary, MD, PhD, discusses the repeat ranking of the USC Norris Blood and Marrow Transplant and Cell Therapy Program as one of the nation’s elite allogeneic transplant programs with the highest survival outcomes.

  • By

  • February 13, 2026

  • 12 min

Share

  • 1

    The USC Norris Blood and Marrow Transplant Program ranks among the top allogeneic transplant programs in the U.S. for survival outcomes.

  • 2

    The program achieved a +1 performance score from CIBMTR, indicating exceptional one-year survival rates exceeding national predictions.

  • 3

    USC Norris is one of only four programs to maintain elite status for six consecutive years, showcasing sustained excellence in patient care.

  • 4

    Key advancements include the adoption of haploidentical transplants and innovative immunosuppressive regimens that improve patient outcomes.

  • 5

    The program's multidisciplinary approach integrates expertise across various medical fields, enhancing comprehensive care for transplant patients.

Original Source(s)

Bone Marrow Transplant: How Keck Medicine of USC Is Excelling in Survival Outcomes

  • by

  • February 13, 2026

Related Content

Mechanisms of first-line treatment resistance in diffuse large B-cell lymphoma

Multi-strategy feature selection and multi-model machine learning for prognostic prediction in primary gastric diffuse large B-cell lymphoma

Dana-Farber Research Helps Drive FDA Label Update for Primary CNS Lymphoma

Change removes prior exclusion and may expand access to CAR T-cell therapy for eligible relapsed or refractory patients

  • by

  • February 9, 2026

  • 3 min